Schedule 13G ownership disclosure
Core Laboratories Inc
Common Stock · CUSIP: 21867A105
Event date: 2025-09-30
- Filing-level shares
- 3,047,390
- Percent of class
- 6.49%
- The Vanguard Group
Shares: 3,047,390 · Class: 6.49%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000111
- Form type
- SCHEDULE 13G/A
- Filer
- Core Laboratories Inc. /DE/
- CIK
- CIK 1958086
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership